David Hallal - CEO, Alexion Pharmaceuticals Inc

As of August 10, 2016


David Hallal Net Worth

  • Net worth is estimated to be at least $99.11M
  • Owns at least 189,266 units of Alexion Pharmaceuticals Inc stock
  • Sold an estimated value of $49.07M in the last 7 years at Alexion Pharmaceuticals Inc

David Hallal Trading

  • Largest purchase of shares was 50,000 units , worth over $882.5K on July 16, 2013
  • Largest sale of shares was 50,000 units , worth over $6M on July 16, 2013
  • In total has made about 64 transactions over 7 years
  • Usually trades in February, with the busiest year in 2010
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

David Hallal Mailing Address

  • Mailing address is C/o Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410 CT

Alexion Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

Alexion Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 24,066 units sold on December 21, 2020 by Daniel Bazarko worth over $3.8M
  • In the last 17 years, insiders at Alexion Pharmaceuticals Inc sold an estimated value of $1.09B and bought an estimated value of $426.64M
  • The most active traders are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO
  • Insider trading is most common in February, with the busiest year in 2014

ALEXION PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1